Human Serpin E1/PAI-1 Alexa Fluor® 594-conjugated Antibody

Applications

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Preparation and Storage

Background: Serpin E1/PAI-1

As a member of the Serpin superfamily of serine protease inhibitors, Serpin E1/PAI‑1 is the principal inhibitor of urokinase‑type plasminogen activator (uPA) and tissue‑type PA (1, 2). As important regulators of extracellular matrix remodeling, uPA and PAI‑1 play a major role in many processes such as angiogenesis, tumor invasion and obesity (2‑4). For example, uPA and PAI-1 are the only tumor prognostic factors validated at the highest level of evidence with regard to their clinical utility in breast cancer (5). The human PAI-1 is initially synthesized as 402 amino acid precursor with a N‑terminal signal peptide (6, 7). PAI‑1 may exist in one of two possible conformations, designated as active or latent (8). The purified rhPAI‑1 is active against rhuPA. The heterogeneity at the N‑terminus of the purified recombinant human PAI‑1 has been observed before for both the recombinant and native proteins (9).

Product Datasheets

Related Research Areas

• Adipocytokines
• Alpha Granule Soluble Molecules
• Cancer Biomarkers
• Coagulation
• Complement Pathway
• DNA Damage and Repair
• Enzymes Secreted by Endothelial Cells
• Mesenchymal Cells and EMT
• Plasmin/Plasminogen and Kallikrein/Kinin Systems
• Search Cytokine and Growth Factor Products
• Serine Proteases and Regulators